Results 231 to 240 of about 78,339 (310)

Correction: Clinical outcomes of fibrin glue assisted hemostasis in persistent intraoperative optic disc bleeding

open access: yesInternational Journal of Retina and Vitreous
Saarang Hansraj   +6 more
doaj   +1 more source

Non‐physician delivered intravitreal injection service: A systematic review of safety, implementation, training and patient experience

open access: yesActa Ophthalmologica, Volume 104, Issue 6, Page e615-e629, September 2026.
Abstract The global demand for intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) therapy continues to rise, straining ophthalmic capacity worldwide. Task shifting from physicians to trained non‐physician healthcare professionals has emerged as a potential strategy to expand service delivery.
Trang Truong Laursen   +4 more
wiley   +1 more source

Melioidosis in companion animals: Analysis of 45 Australian cases (24 dogs; 21 cats) from 1997 to 2025 and a brief review of the animal and human literature

open access: yesAustralian Veterinary Journal, Volume 104, Issue 9, Page 563-580, September 2026.
Objective To report 45 cases of melioidosis in dogs and cats from northern Australia and analyse trends in epidemiology, clinical presentation, pathogenesis and response to treatment over a 27‐year period. Design Retrospective and prospective analysis of clinical records.
K Lee   +6 more
wiley   +1 more source

Processionary Moth Exposure in Europe: Toxic–Irritant and Immunoglobulin E‐Mediated Endotypes, Diagnosis and Management

open access: yesClinical &Experimental Allergy, Volume 56, Issue 9, Page 1017-1030, September 2026.
Most reactions are toxic–irritant, driven by epithelial injury and neuro‐inflammatory activation. IgE‐mediated allergy is less common but may cause immediate systemic reactions. Endotype differentiation guides diagnosis, risk stratification and management.
Prasad Dasari   +9 more
wiley   +1 more source

Langzeit‐Krebsüberleben (Survivorship) beim malignen Melanom

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 9, Page 1291-1309, September 2026.
Zusammenfassung Für das metastasierte Melanom liegen inzwischen robuste Daten zum Langzeitüberleben vor; so beträgt unter kombinierter Therapie mit Immuncheckpointinhibitoren (ICI) im metastasierten Stadium die melanomspezifische 10‐Jahres‐Überlebensrate über 50 %.
Markus Reitmajer   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy